Encephalitis, Japanese B Completed Phase 4 Trials for Japanese encephalitis vaccine (live, attenuated) (DB16577)

Also known as: Japanese Encephalitis / Encephalitis Japanese B / Encephalitis, Japanese / Japanese B encephalitis / Japanese B viral encephalitis

IndicationStatusPhase
DBCOND0033957 (Encephalitis, Japanese B)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01981967Post-licensure Safety Study of IMOJEVĀ® in ThailandPrevention
NCT02514746Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster DosePrevention
NCT02880865Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) VaccinePrevention